UW Medicine newsroom | May 28, 2024
Research led by Jeff Iliff, PhD, may explain why veterans who have experienced explosion-caused concussions are more likely to develop psychiatric disorders and cognitive impairment.
Research & Innovation
Dr. Jesse Fann: Biden Cancer Moonshot
The White House | May 29, 2024
Jesse Fann, MD, MPH, shared his work at the intersection of mental health and oncology as part of the Biden Cancer Moonshot’s effort to recognize Mental Health Awareness Month.
Mushrooms may not be magic, but they could be therapeutic
Seattle Met | May 30, 2024
Nathan Sackett, MD, MS, is heading up a study to explore the potential therapeutic value of psilocybin, the psychedelic compound found in mushrooms.
Initiative awards 13 early-stage pilot grants to teams of interdisciplinary UW investigators
Population Health Initiative | May 20, 2024
The UW Population Health Initiative announced the award of 13 pilot grants to teams of interdisciplinary researchers. Jessica Acolin, PhD, Brittney Hultgren, PhD, Jason Kilmer, PhD, and McKenna Parnes, PhD, received a grant to produce a brief measure of climate change distress that may be included in epidemiologic surveys.
Scaling telepsychiatry Collaborative Care for complex psychiatric disorders
Department news | April 30, 2024
AIMS Center faculty members John Fortney, PhD, and Amy Bauer, MD, MS, will lead a three-year, multi-state project to facilitate mental health care for patients with complex psychiatric disorders in primary care settings.
What marijuana reclassification means for the United States
Associated Press | May 1, 2024
Susan Ferguson, PhD, says reclassifying marijuana as a less dangerous drug would open the door for researchers.
New $12.6M grant to help unravel hallucinations
UW Medicine newsroom | April 29, 2024
Dror Ben-Zeev, PhD, and Trevor Cohen, MBChB, PhD, FACMI (Biomedical Informatics and Medical Education) received a five-year, $12.6 million grant from NIMH to create a new digital evaluation tool for people who experience hallucinations.
UW’s “magic mushroom” trial advancing
Axios Seattle | April 30, 2024
A study led by Nathan Sackett, MD, MS, on the therapeutic value of psychedelic mushrooms for treating addiction and trauma is on track. The project will enroll about 40 first responders and Veterans with PTSD and alcohol use disorder starting this fall.
Caring letters show mixed results for veterans in crisis
UW Medicine newsroom | April 30, 2024
A large study led by Mark Reger, PhD, found that Caring Letters did not reduce the occurrence of suicide attempts among veterans who called a crisis hotline, but they did spur callers to use Veterans Health Administration mental health resources.
Virtual reality environment for teens may offer an accessible, affordable way to reduce stress
UW News | May 1, 2024
An ALACRITY Center-funded study found that teens who used virtual reality reported lower stress levels and improved mood. Michael Pullmann, PhD, was a co-author of the study.
